Gene · 10549
Papers1,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maresin1 ameliorates MSU crystal-induced inflammation by upregulating Prdx5 expression. | Mol Med | 2023 | 37996809 | PubTator, text mining | PubMed |
| Correction: Comprehensive analysis of peroxiredoxins expression profiles and prognostic values in breast cancer. | Biomark Res | 2023 | 37941057 | PubTator, text mining | PubMed |
| Spatially resolved mapping of proteome turnover dynamics with subcellular precision. | Nat Commun | 2023 | 37940635 | PubTator, text mining | PubMed |
| A De Novo Deleterious PHEX Variant Without Clinical Features of X-Linked Hypophosphatemia. | JCEM Case Rep | 2023 | 37908207 | PubTator, text mining | PubMed |
| Secretome analysis of breast cancer cells to identify potential target proteins of Ipomoea turpethum extract-loaded nanoparticles in the tumor microenvironment. | Front Cell Dev Biol | 2023 | 37900279 | PubTator, text mining | PubMed |
| The role of red ginseng in men's reproductive health: a literature review. | Basic Clin Androl | 2023 | 37880595 | PubTator, text mining | PubMed |
| Ferroptosis precedes apoptosis to facilitate specific death signalling by fatty acids. | Proc Biol Sci | 2023 | 37876198 | PubTator, text mining | PubMed |
| High-Resolution Structural Proteomics of Mitochondria Using the 'Build and Retrieve' Methodology. | Mol Cell Proteomics | 2023 | 37839702 | PubTator, text mining | PubMed |
| Calcein-Modified CeO2 for Intracellular ROS Detection: Mechanisms of Action and Cytotoxicity Analysis In Vitro. | Cells | 2023 | 37830630 | PubTator, text mining | PubMed |
| Single-cell dissection, hdWGCNA and deep learning reveal the role of oxidatively stressed plasma cells in ulcerative colitis. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37814814 | PubTator, text mining | PubMed |
The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role. | Histol Histopathol | 2023 | 37787446 | PubTator, text mining | PubMed |
| Precise Orchestration of Gasdermins' Pore-Forming Function by Posttranslational Modifications in Health and Disease. | Int J Biol Sci | 2023 | 37781519 | PubTator, text mining | PubMed |
| The Antitumor Activity of Piplartine: A Review. | Pharmaceuticals (Basel) | 2023 | 37765054 | PubTator, text mining | PubMed |
| Pitfalls of Mitochondrial Redox Signaling Research. | Antioxidants (Basel) | 2023 | 37759999 | PubTator, text mining | PubMed |
| The Regenerative Power of Stem Cells: Treating Bleomycin-Induced Lung Fibrosis. | Stem Cells Cloning | 2023 | 37719787 | PubTator, text mining | PubMed |
| Secretome profiling of Artemisia absinthium extract-loaded polymeric nanoparticle-treated MCF-7 and MDA-MB-231 revealed perturbation in microtubule assembly and cell migration. | Front Oncol | 2023 | 37719007 | PubTator, text mining | PubMed |
| Endoplasmic reticulum stress: molecular mechanism and therapeutic targets. | Signal Transduct Target Ther | 2023 | 37709773 | PubTator, text mining | PubMed |
| Single-Cell Transcriptional and Epigenetic Profiles of Male Breast Cancer Nominate Salient Cancer-Specific Enhancers. | Int J Mol Sci | 2023 | 37685859 | PubTator, text mining | PubMed |
| Proteomics in Childhood Acute Lymphoblastic Leukemia: Challenges and Opportunities. | Diagnostics (Basel) | 2023 | 37685286 | PubTator, text mining | PubMed |
| Macrophage Implication in IPF: Updates on Immune, Epigenetic, and Metabolic Pathways. | Cells | 2023 | 37681924 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10549/papers?page=6